# Early Salvage Therapy for Patients With Advanced Features for Biochemical Relapse After Radical Prostatectomy for Localized Prostate Carcinoma In Correlation With Supposed Molecular-genetic Parameters of Higher Aggressiveness

> **NCT05232578** · PHASE3 · NOT_YET_RECRUITING · sponsor: **General University Hospital, Prague** · enrollment: 380 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Early salvage radiotherapy (eSRT)
- **RADIATION:** Delayed Salvage radiotherapy (dSRT)

## Key facts

- **NCT ID:** NCT05232578
- **Lead sponsor:** General University Hospital, Prague
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-09
- **Primary completion:** 2032-12
- **Final completion:** 2032-12
- **Target enrollment:** 380 (ESTIMATED)
- **Last updated:** 2022-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05232578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05232578, "Early Salvage Therapy for Patients With Advanced Features for Biochemical Relapse After Radical Prostatectomy for Localized Prostate Carcinoma In Correlation With Supposed Molecular-genetic Parameters of Higher Aggressiveness". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05232578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*